ASX:NYR

Nyrada Competitors

Add

Compare

Today's Range N/A

50-Day Range

A$0.17

MA: A$0.16▼

A$0.17

52-Week Range N/A

Volume65,000 shs

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Nyrada (ASX:NYR) Vs. CHV, DDXS, PREV, TNGN, COM, and MYM

Should you be buying NYR stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to Nyrada, including (CHV) (CHV), (DDXS) (DDXS), (PREV) (PREV), (TNGN) (TNGN), 138267 (COM.TO) (COM), and 17031 (MYM).

Nyrada vs. (CHV) Stock

(CHV) (CNSX:CHV) and Nyrada (ASX:NYR) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation and risk.

Analyst Ratings

This is a summary of recent ratings and price targets for (CHV) and Nyrada, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
(CHV)	0	0	0	0	N/A
Nyrada	0	0	0	0	N/A

Profitability

This table compares (CHV) and Nyrada's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
(CHV)	N/A	N/A	N/A
Nyrada	N/A	N/A	N/A

Valuation and Earnings

This table compares (CHV) and Nyrada's top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
(CHV)	N/A	N/A	N/A	N/A	N/A
Nyrada	$1.18 million	0.00	$-6,317,082.00	A($0.06)	N/A

(CHV) has higher earnings, but lower revenue than Nyrada.

Summary

Nyrada beats (CHV) on 1 of the 1 factors compared between the two stocks.

Nyrada vs. (DDXS) Stock

Nyrada (ASX:NYR) and (DDXS) (OTCMKTS:DDXS) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, risk, earnings and dividends.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Nyrada and (DDXS), as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nyrada	0	0	0	0	N/A
(DDXS)	0	0	0	0	N/A

Profitability

This table compares Nyrada and (DDXS)'s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nyrada	N/A	N/A	N/A
(DDXS)	N/A	N/A	N/A

Valuation & Earnings

This table compares Nyrada and (DDXS)'s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nyrada	$1.18 million	0.00	$-6,317,082.00	A($0.06)	N/A
(DDXS)	N/A	N/A	N/A	N/A	N/A

(DDXS) has lower revenue, but higher earnings than Nyrada.

Summary

Nyrada beats (DDXS) on 1 of the 1 factors compared between the two stocks.

Nyrada vs. (PREV) Stock

Nyrada (ASX:NYR) and (PREV) (CNSX:PREV) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, risk, earnings and dividends.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Nyrada and (PREV), as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nyrada	0	0	0	0	N/A
(PREV)	0	0	0	0	N/A

Profitability

This table compares Nyrada and (PREV)'s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nyrada	N/A	N/A	N/A
(PREV)	N/A	N/A	N/A

Valuation & Earnings

This table compares Nyrada and (PREV)'s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nyrada	$1.18 million	0.00	$-6,317,082.00	A($0.06)	N/A
(PREV)	N/A	N/A	N/A	N/A	N/A

(PREV) has lower revenue, but higher earnings than Nyrada.

Summary

Nyrada beats (PREV) on 1 of the 1 factors compared between the two stocks.

Nyrada vs. (TNGN) Stock

Nyrada (ASX:NYR) and (TNGN) (OTCMKTS:TNGN) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, risk, earnings and dividends.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Nyrada and (TNGN), as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nyrada	0	0	0	0	N/A
(TNGN)	0	0	0	0	N/A

Profitability

This table compares Nyrada and (TNGN)'s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nyrada	N/A	N/A	N/A
(TNGN)	N/A	N/A	N/A

Valuation & Earnings

This table compares Nyrada and (TNGN)'s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nyrada	$1.18 million	0.00	$-6,317,082.00	A($0.06)	N/A
(TNGN)	N/A	N/A	N/A	N/A	N/A

(TNGN) has lower revenue, but higher earnings than Nyrada.

Summary

Nyrada beats (TNGN) on 1 of the 1 factors compared between the two stocks.

Nyrada vs. 138267 (COM.TO) Stock

Nyrada (ASX:NYR) and 138267 (COM.TO) (TSE:COM) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, risk, earnings and dividends.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Nyrada and 138267 (COM.TO), as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nyrada	0	0	0	0	N/A
138267 (COM.TO)	0	0	0	0	N/A

Profitability

This table compares Nyrada and 138267 (COM.TO)'s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nyrada	N/A	N/A	N/A
138267 (COM.TO)	N/A	N/A	N/A

Valuation & Earnings

This table compares Nyrada and 138267 (COM.TO)'s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nyrada	$1.18 million	0.00	C$-6,317,082.00	A($0.06)	N/A
138267 (COM.TO)	N/A	N/A	N/A	N/A	N/A

138267 (COM.TO) has lower revenue, but higher earnings than Nyrada.

Summary

Nyrada beats 138267 (COM.TO) on 1 of the 1 factors compared between the two stocks.

Nyrada vs. 17031 Stock

Nyrada (ASX:NYR) and 17031 (CNSX:MYM) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, risk, earnings and dividends.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Nyrada and 17031, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nyrada	0	0	0	0	N/A
17031	0	0	0	0	N/A

Profitability

This table compares Nyrada and 17031's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nyrada	N/A	N/A	N/A
17031	N/A	N/A	N/A

Valuation & Earnings

This table compares Nyrada and 17031's gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nyrada	$1.18 million	0.00	C$-6,317,082.00	A($0.06)	N/A
17031	N/A	N/A	N/A	N/A	N/A

17031 has lower revenue, but higher earnings than Nyrada.

Summary

Nyrada beats 17031 on 1 of the 1 factors compared between the two stocks.